We're thrilled to announce the #publication of our #research paper titled "Assessing the Performance of a Novel Stool-Based Microbiome Test That Predicts Response to First Line Immune Checkpoint Inhibitors in Multiple Cancer Types" published in
#Cancers: https://t.co/5uZg1jOh9o
Bacteroides, Ruminococcus, Eubacterium, and Akkermansia were identified as key determinants of CAR-T responsiveness, providing a basis for cross-cohort microbiome-based predictions in CAR-T cell immunotherapy.
https://t.co/mI7ZYBJUaF
#BiomeDx#startup#scicomm
A recent article published in Cell Host & Microbe provides a comprehensive analysis of the factors influencing #FMT success and highlights the need for an integrated approach to further enhance outcomes.
🔗 Link to the full article below:
https://t.co/3p9pXVNJMU
Are you looking for a microbiome expert partner to kickstart your clinical trial, research project or grant application? 🔬💡
Reach out to us and start planning your next experiment! 🧪
#BiomeDx#guthealth#gutmicrobiome#microbiomeanalysis
#BiomeDx has made it to the finals of the prestigious EIT Health Catapult program. Stay tuned for updates on our progress in the finals which will be hosted at the Bits&Pretzels 🥨 #HealthTech conference, and thank you for your ongoing support! 😎
A new study recently published in Current Oncology shows a dysregulation of the intestinal #microbiome in patients with hepatocellular carcinoma. New targets for therapeutic interventions and #immunotherapy?👇
https://t.co/X1BCQKCCRS
#BiomeDx#medtech#sciencecommunication
🤩 We wanted to share how awesome the last week was at the founders’ dinner organized together with @speedinvest . We had a blast talking and exchanging ideas with truly amazing people. 💫 Can´t wait for the next one!
🚨 Out now: new publication about gut microbiome analysis and colorectal cancer screening. Thank you all for this amazing study ⬇️ @stefaniebrezina
https://t.co/8lYDsKTCut
#ASCO23 abstract submissions are open!
Submit your cutting-edge and clinically relevant research to the world’s largest clinical cancer research meeting ➡️ https://t.co/nesEYLodNZ
A joint collaboration between the @MDAndersonNews and @FederationBio aims to overcome the current drawbacks of using FMT 💩 to enhance therapeutic benefit in cancer patients treated with immunotherapy 👇
https://t.co/Fq8kilDO7c
📢 EU Country #Cancer Profiles: now available!
National cancer burden, risk factors, early detection programmes, cancer care performance, etc. ⬇️
https://t.co/ClBDLfaQ4r
#BiomeDx#oncology
#Tumorimmunologie, #Immuntherapie und #Mikrobiom: Laurence Zitvogel vom @gustaveroussy#Cancer Center gibt am 16.02. Einblicke in ihre Forschung. Melden Sie sich noch bis zum 9.02. zur Regine Kapeller-Adler Lecture des vfwf an! Alle Details ➡️ https://t.co/kAQuHoI9Gh
A recent publication in @Nature quenched the debate about whether the #human fetus and the intrauterine environment are sterile or not. 👶🏾👶🏼The authors suggest that microbial colonisation occurs only after #birth and not in utero🤰🏽👩🏼🍼
https://t.co/F9lkKP39FR